Results 151 to 160 of about 7,224 (167)

Tenofovir alafenamide use in pregnant and lactating women living with HIV

Expert Opinion on Drug Metabolism and Toxicology, 2020
Jeanne Sheffield, Kelly Dooley, Ahizechukwu C Eke   +2 more
exaly  

Tenofovir-alafenamide/tenofovir-disoproxil-fumarate

Reactions Weekly, 2018
openaire   +1 more source

Tenofovir alafenamide in the treatment of chronic hepatitis B virus infection: rationale and clinical trial evidence

Therapeutic Advances in Gastroenterology, 2018
Ivana Carey, Kosh Agarwal
exaly  

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

Lancet, The, 2017
Paul Edward Sax, Anton Pozniak, Kirsten White   +2 more
exaly  

Emtricitabine/tenofovir alafenamide

Reactions Weekly, 2017
openaire   +1 more source

Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults

Expert Opinion on Pharmacotherapy, 2016
Stefano Bonora, Alice Trentalange, Andrea Calcagno   +2 more
exaly  

Gentamicin/tenofovir alafenamide

Reactions Weekly, 2020
openaire   +1 more source

Tenofovir alafenamide/emtricitabine

Reactions Weekly, 2017
openaire   +1 more source

Rare emergence of drug resistance in HIV-1 treatment -naïve patients after 48 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide

HIV Clinical Trials, 2016
Nicolas Margot, Scott Mccallister, Christian Callebaut   +2 more
exaly  

Adefovir/tenofovir-alafenamide

Reactions Weekly, 2019
openaire   +1 more source